110 related articles for article (PubMed ID: 38837741)
1. Allelic loss of HLA class I facilitates evasion from immune surveillance in cervical intraepithelial neoplasia.
Kawase K; Taguchi A; Ishizaka A; Lin J; Ueno T; Yoshimoto D; Eguchi S; Mori S; Sone K; Mori M; Yonekura S; Hanazawa T; Maeda D; Kukimoto I; Mano H; Osuga Y; Kawana K; Kawazu M
HLA; 2024 Jun; 103(6):e15509. PubMed ID: 38837741
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the frequency of genetic alterations (LOH/MSI) in patients with intraepithelial cervical lesions with HPV infection: a pilot study.
Migdalska-Sęk M; Karowicz-Bilińska A; Pastuszak-Lewandoska D; Czarnecka KH; Nawrot E; Domańska-Senderowska D; Kiszałkiewicz J; Brzeziańska-Lasota E
Med Oncol; 2016 May; 33(5):51. PubMed ID: 27090798
[TBL] [Abstract][Full Text] [Related]
3. Frequent HLA class I loss is an early event in cervical carcinogenesis.
Vermeulen CF; Jordanova ES; Zomerdijk-Nooijen YA; ter Haar NT; Peters AA; Fleuren GJ
Hum Immunol; 2005 Nov; 66(11):1167-73. PubMed ID: 16571417
[TBL] [Abstract][Full Text] [Related]
4. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
Bontkes HJ; van Duin M; de Gruijl TD; Duggan-Keen MF; Walboomers JM; Stukart MJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ; Stevens FR; Dyer PA; Sinnott P; Stern PL
Int J Cancer; 1998 Oct; 78(2):166-71. PubMed ID: 9754647
[TBL] [Abstract][Full Text] [Related]
5. HLA and susceptibility to cervical neoplasia.
Krul EJ; Schipper RF; Schreuder GM; Fleuren GJ; Kenter GG; Melief CJ
Hum Immunol; 1999 Apr; 60(4):337-42. PubMed ID: 10363725
[TBL] [Abstract][Full Text] [Related]
6. Association of human leukocyte antigen and T cell message with human papillomavirus 16-positive cervical neoplasia in Japanese women.
Saito M; Okubo M; Hirata R; Takeda S; Maeda H
Int J Gynecol Cancer; 2007; 17(6):1314-21. PubMed ID: 17433060
[TBL] [Abstract][Full Text] [Related]
7. HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection.
Glew SS; Connor ME; Snijders PJ; Stanbridge CM; Buckley CH; Walboomers JM; Meijer CJ; Stern PL
Eur J Cancer; 1993; 29A(14):1963-70. PubMed ID: 8280490
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between human papillomavirus type 16 infection and human leukocyte antigen class I expression in cervical cancers of Uighur women].
Ma Q; Hasim A; Abudukadeer A; Yilike X; Wu GZ; Abudula A
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):255-8. PubMed ID: 20654125
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix.
Ferguson R; Ramanakumar AV; Koushik A; Coutlée F; Franco E; Roger M;
Int J Cancer; 2012 Aug; 131(3):E312-9. PubMed ID: 22095460
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response.
Dong DD; Yang H; Li K; Xu G; Song LH; Fan XL; Jiang XL; Yie SM
Reprod Sci; 2010 Aug; 17(8):718-23. PubMed ID: 20445010
[TBL] [Abstract][Full Text] [Related]
11. Expression and genetic analysis of transporter associated with antigen processing in cervical carcinoma.
Vermeulen CF; Jordanova ES; ter Haar NT; Kolkman-Uljee SM; de Miranda NF; Ferrone S; Peters AA; Fleuren GJ
Gynecol Oncol; 2007 Jun; 105(3):593-9. PubMed ID: 17382375
[TBL] [Abstract][Full Text] [Related]
12. Association of HLA class I and II genes with cervical cancer susceptibility in a Han Chinese population.
Yao Y; Yan Z; Li C; Zhang S; Liu S; Zhang X; Shi L; Liu W; Shi L; Yao Y
HLA; 2024 Jan; 103(1):e15340. PubMed ID: 38212262
[TBL] [Abstract][Full Text] [Related]
13. [Loss of heterozygosity at chromosome 6 as a marker of early genetic alterations in cervical intraepithelial neoplasias and microinvasive carcinomas].
Mazurenko NN; Bliev AIu; Bidzhieva BA; Peskov DIu; Snigur NV; Savinova EB; Kiselev FL
Mol Biol (Mosk); 2006; 40(3):436-47. PubMed ID: 16813163
[TBL] [Abstract][Full Text] [Related]
14. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E
J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005
[TBL] [Abstract][Full Text] [Related]
15. Selected class I and class II HLA alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia.
Ades S; Koushik A; Duarte-Franco E; Mansour N; Arseneau J; Provencher D; Gilbert L; Gotlieb W; Ferenczy A; Coutlée F; Roger M; Franco EL;
Int J Cancer; 2008 Jun; 122(12):2820-6. PubMed ID: 18351579
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
Yang W; Song Y; Lu YL; Sun JZ; Wang HW
Immunology; 2013 Aug; 139(4):513-22. PubMed ID: 23521696
[TBL] [Abstract][Full Text] [Related]
17. Expression of p16
Badiga S; Chambers MM; Huh W; Eltoum IA; Piyathilake CJ
Cancer; 2016 Dec; 122(23):3615-3623. PubMed ID: 27479745
[TBL] [Abstract][Full Text] [Related]
18. Cervical intraepithelial neoplasia: prognosis by combined LOH analysis of multiple loci.
ELhamidi A; Hamoudi RA; Kocjan G; Du MQ
Gynecol Oncol; 2004 Sep; 94(3):671-9. PubMed ID: 15350357
[TBL] [Abstract][Full Text] [Related]
19. Regression of low-grade cervical intraepithelial neoplasia in patients with HLA-DRB1*13 genotype.
Sastre-Garau X; Cartier I; Jourdan-Da Silva N; De Crémoux P; Lepage V; Charron D
Obstet Gynecol; 2004 Oct; 104(4):751-5. PubMed ID: 15458897
[TBL] [Abstract][Full Text] [Related]
20. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
